Used in the synthesis of non-steroidal anti-inflammatory drugs (NSAIDs) due to its structural similarity to known anti-inflammatory agents. Its derivatives show potential in inhibiting cyclooxygenase (COX) enzymes, reducing prostaglandin production, and thus alleviating pain and inflammation. Also investigated for use in developing new analgesic and antipyretic compounds. The compound serves as an intermediate in pharmaceutical research, particularly in designing molecules with improved bioavailability and reduced gastrointestinal side effects.